artience Rolls Out Functional Synthetic Polymers for In Vitro Diagnostics

artience Co., Ltd. will be rolling out the Sciforiem™ PL 1000 Series of functional synthetic polymers to markets outside of Japan, beginning July 2025.

Sciforiem polymers are synthesized from non-biological raw materials and can be engineered to replicate biological functions, making them valuable for the development of biosensors, diagnostic assays and other in vitro diagnostic (IVD) systems.

IVDs are medical devices used to analyze biological samples like blood or tissue to diagnose diseases. Sciforiem PL 1000 polymers are specially optimized for use in IVDs that rely on antigen-antibody reactions to detect target molecules.

When used to coat the substrate material in antigen-antibody reaction detection, these polymers can prevent non-specific protein adsorption, enhance detection sensitivity and stabilize proteins, thus improving overall reagent performance.

Such biological functions performed by Sciforiem polymers are useful in various applications, such as blocking agents in immunoassays like ELISA and immunochromatography or as protein stabilizers in IVD assays. In biomolecule research, they act as additives in diagnostic reagents due to their ability to enhance functionality and stability.

 “Historically, bio raw materials were considered a biomanufacturing challenge for their inconsistent quality,” says Nozomu Hatano, GM of artience’s Biotech Business Unit in Japan. “By adopting artience’s polymer design and dispersion technologies to address stability issues in raw materials, our engineers were able to fabricate a functional polymer for in vitro diagnostic reagents that exhibit minimal variation in quality. We expect the new Sciforiem PL 1000 Series to significantly reduce diagnostic errors and improve patient care, going forward.”

The Sciforiem Series of life science products from artience will be making its global debut at ADLM 2025 (or ADLM Annual Scientific Meeting & Clinical Lab Expo), in Chicago, from July 27–31, 2025.